CD4 and neoplasm: However, despite these well-established notions, it has been recently known that the deletion of MHC-II and CD40 in cDC1 also prevented early CD4 T cell priming and impaired tumor rejection in fibrosarcoma-bearing mice, thus suggesting that cDC1s are also required for CD4 T cell priming against TAAs (76).